Home / Inspections / 1312310

FDA Inspection 1312310 — Reproductive Gynecology Laboratories

Reproductive Gynecology Laboratories — FEI 3003928276

The FDA completed an inspection of Reproductive Gynecology Laboratories on April 7, 2026 in Akron, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 7, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Akron, OH (United States)

Facility

Other inspections at this facility

  • 1194799 (NAI Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1110089 (NAI Thu Nov 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1032534 (NAI Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 903327 (NAI Thu Nov 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 813223 (VAI Tue Jan 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources